Homocysteine as a determinant of left ventricular ejection fraction in patients with diabetes

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 6, 2012, Pages 1099-1106

  Badiou, Stephanie ^a,b   Dupuy, Anne Marie ^a   Jaussent, Isabelle ^c   Sultan, Ariane ^a,d,e   Mariano Goulart, Denis ^a   Cristol, Jean Paul ^a,b   Avignon, Antoine ^a,d,e  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b University Montpellier 1 et 2   (France)

^c INSERM U1061   (France)

^d UNIV MONTPELLIER   (France)

^e INSERM   (France)

Author keywords

Diabetes; Homocysteine; Left ventricular ejection fraction

Indexed keywords

HOMOCYSTEINE; BIOLOGICAL MARKER;

ADULT; AGED; ALBUMINURIA; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL PERFUSION IMAGING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SILENT MYOCARDIAL ISCHEMIA; SMOKING; UNIVARIATE ANALYSIS; ANALYSIS OF VARIANCE; BLOOD; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84867432844     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2011-0851     Document Type: Article

References (30)

1. Kenchaiah S, Narula J, Vasan RS. Risk factors for heart failure. Med Clin North Am 2004;88:1145-72.
2. Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 2001;24:1614-9.
3. Vasan RS, Beiser A, D'Agostino RB, Levy D, Selhub J, Jacques PF, et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA 2003;289:1251-7.
4. Herrmann M, Müller S, Kindermann I, Günther L, König J, Böhm M, et al. Plasma B vitamins and their relation to the severity of chronic heart failure. Am J Clin Nutr 2007;85:117-23.
5. Guéant-Rodriguez RM, Juillière Y, Nippert M, Abdelmouttaleb I, Herbeth B, Aliot E, et al. Left ventricular systolic dysfunction is an independent predictor of homocysteine in angiographically documented patients with or without coronary artery lesions. J Thromb Haemost 2007;5:1209-16.
6. Nasir K, Tsai M, Rosen BD, Fernandes V, Bluemke DA, Folsom AR, et al. Elevated homocysteine is associated with reduced regional left ventricular function: the Multi-Ethnic Study of Atherosclerosis. Circulation 2007;115:180-7.
7. Pietrzik K, Brönstrup A. Vitamins B12, B6 and folate as determinants of homocysteine concentration in the healthy population. Eur J Pediatr 1998;157:135-8.
8. Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest 1996;56:41-6.
9. Ndrepepa G, Kastrati A, Braun S, Koch W, Kölling K, Mehilli J, et al. Circulating homocysteine levels in patients with type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2008;18:66-73.
10. Schäfer SA, Müssig K, Stefan N, Häring HU, Fritsche A, Balletshofer BM. Plasma homocysteine concentrations in young individuals at increased risk of type 2 diabetes are associated with subtle differences in glomerular filtration rate but not with insulin resistance. Exp Clin Endocrinol Diabetes 2006;114:306-9.
11. The expert committee on the diagnosis and classification of diabetes mellitus: report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-97.
12. Sultan A, Piot C, Mariano-Goulart D, Daures JP, Comte F, Renard E, et al. Myocardial perfusion imaging and cardiac events in a cohort of asymptomatic patients with diabetes living in southern France. Diabet Med 2006;23:410-8.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine, a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
14. Bravo PE, Chien D, Javadi M, Merrill J, Bengel FM. Reference ranges for LVEF and LV volumes from electrocardiographically gated 82Rb cardiac PET/CT using commercially available software. J Nucl Med 2010;51:898-905.
15. Iribarren C, Karter AJ, Go AS, Ferrara A, Liu J Y, Sidney S, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation 2001;103:2668-73.
16. Nichols GA, Guillon CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 2004;27:1879-84.
17. Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr. Heart failure prevalence, incidence and mortality in the elderly with diabetes. Diabetes Care 2004;27:699-703.
18. Cesari M, Zanchetta M, Burlina A, Pedon L, Maiolino G, Sticchi D, et al. Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives. Arterioscler Thromb Vasc Biol 2005;25:115-21.
19. Joseph J, Joseph L, Shekhawat NS, Devi S, Wang J, Melchert RB, et al. Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am J Physiol Heart Circ Physiol 2003;285:H679-86.
20. Herrmann M, Taban-Shoma O, Hübner U, Pexa A, Kilter H, Umanskaya N, et al. Hyperhomocysteinemia and myocardial expression of brain natriuretic peptide in rats. Clin Chem 2007;53:773-80.
21. Rosenberger D, Gargoum R, Tyagi N, Metreveli N, Sen U, Maldonado C, et al. Homocysteine enriched diet leads to prolonged QT interval and reduced left ventricular performance in telemetric monitored mice. Nutr Metab Cardiovasc Dis 2011;21:492-8.
22. Devi S, Kennedy RH, Joseph L, Shekhawat NS, Melchert RB, Joseph J. Effect of long-term hyperhomocysteinemia on myocardial structure and function in hypertensive rats. Cardiovasc Pathol 2006;15:75-82.
23. Edirimanne VE, Woo CW, Siow YL, Pierce GN, Xie JY. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats. Can J Physiol Pharmacol 2007;85:1236-47.
24. Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function. Curr Drug Metab 2005;6:27-36.
25. Ventura E, Durant R, Jaussent A, Picot MC, Morena M, Badiou S, et al. Homocysteine and inflammation as main determinants of oxidative stress in the elderly. Free Radic Biol Med 2009;46:737-44.
26. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al. Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006;354:1567-77.
27. Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006;354:1578-88.
28. Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, et al. Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH) Collaborative Group, Effects of homocysteine-lowering with folic acid plus vitamin B12 vs. placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 2010;303:2486-94.
29. House AA, Eliasziw M, Cattran DC, Churchill DN, Oliver MJ, Fine A, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 2010;303:1603-9.
30. Joseph J, Joseph L, Devi S, Kennedy RH. Effect of antioxidant treatment on hyperhomocysteinemia-induced myocardial fibrosis and diastolic dysfunction. Heart Lung Transplant 2008;27:1237-41